Flow Cytometry in Oncology and Immunology Market Exclusive Overview Report for 2024-2031

Flow Cytometry in Oncology and Immunology Market Exclusive Overview Report for 2024-2031
Flow Cytometry in Oncology and Immunology Market
“Flow Cytometry in Oncology and Immunology Market” in terms of revenue was estimated to be worth $2.02 billion in 2023 and is poised to reach $4.63 billion by 2031

“Flow Cytometry in Oncology and Immunology Market” in terms of revenue was estimated to be worth $2.02 billion in 2023 and is poised to reach $4.63 billion by 2031, growing at a CAGR of 11.12% from 2023 to 2031 according to a new report by InsightAce Analytic.


Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1491

Latest Drivers Restraint and Opportunities Market Snapshot:


Key factors influencing the Flow Cytometry in Oncology and Immunology Market are:

  • Improvements in flow cytometry technology
  • Increasing number of cancer instances
  • Rising consciousness


The following are the primary obstacles to the Flow Cytometry in Oncology and Immunology Market ‘s expansion:

  • High cost
  • Lack of qualified workers
  • False Positive and Negative Antibody Reactions.


Future expansion opportunities for the Flow Cytometry in Oncology and Immunology Market include:  

  • Growing Role in Academic Research
  • Increasing investment in research and development
  • Growing population


Market Analysis:


Global flow cytometry in oncology and immunology is a mature market with promising prospects, such as the growing body of literature on using flow cytometry in solid tumor detection and the potential for public-private partnerships to boost research and development in immunology and oncology. The worldwide market for flow cytometry in immunology and oncology is poised for significant growth due to the growing interest in using the technology to detect solid tumors and adopting public-private partnerships to enhance research and development in these areas.


List of Prominent Players in the Flow Cytometry in Oncology and Immunology Market:

  • Agilent Technologies, Inc.
  • Becton, Dickinson,
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Cytec Biosciences, Inc.
  • Danaher Corporation
  • Diasporic S.p.A (Luminex Corporation)
  • Enzi Beachem Inc.
  • Laboratory Corporation of America Holdings
  • Merck Kagan
  • Millenia Biotic
  • Neo Genomics Laboratories, Inc.
  • OPKO Health, Inc.
  • Sony Group Corporation
  • Thermos Fisher Scientific Inc


Flow Cytometry in Oncology and Immunology Market Report Scope:


Report Attribute


Market size value in 2023

USD 2.02 billion

Revenue forecast in 2031

USD 4.63 billion

Growth rate CAGR

CAGR of 11.12% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Million, and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year


Report coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments covered

By Offering, Technology, Type, Application, End-User

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa


Recent Developments:

  • In January 2024, Agilent Technologies Inc. revealed its ProteoAnalyzer system, an automated parallel capillary electrophoresis technology for protein analysis, at the 23rd Annual PepTalk Conference in San Diego.
  • In January 2024, Thermo Fisher Scientific’s newest and biggest array, the AxiomTM PangenomiX Array, offers unparalleled genetic coverage for pharmacogenomic and large-scale illness studies.
  • In January 2024, Becton, Dickinson, and Company (BD), a prominent worldwide medical technology company, and Hamilton, a prominent worldwide manufacturer of laboratory automation technology, announced a partnership to create robotics-compatible reagent kits and automated applications that will allow for larger-scale single-cell multi-omics experiments to be conducted with more standardization and less human error.


Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1491


Flow Cytometry in Oncology and Immunology Market Dynamics:

Market Drivers: Improvements in Flow Cytometry Technology

The development and commercialization of technologically sophisticated flow cytometry products that provide simplified workflows, easy operability, and improved turnaround times are gaining prominence in the global market. This leads to the creation of flow cytometry devices that are novel, small, easy to use, and inexpensive. Particularly in established markets with a high adoption rate of technologically sophisticated products, such novel items will play a substantial role as drivers throughout the projection period.


Challenges: High Cost

The entire cost of ownership of these instruments increases due to maintenance charges and other indirect expenses. Particularly in developing countries, the optimal use of flow cytometry devices in clinical and research applications is impeded by increased product installation costs and expenditures. It has been noted that cell analyzers are more affordable than flow cytometry-based cell sorters; thus, the market will be limited by higher prices.


North America is Expected to Grow with the Highest CAGR During the Forecast Period

The North America Flow Cytometry in Oncology and Immunology Market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the increasing funding and grants from the government and HIV/AIDS, a growing emphasis on finding treatments for specific diseases (like cancer and immunological disorders), and the involvement of influential figures. Flow cytometry is seeing growth in these countries for several reasons, including a decrease in the complexity of regulations around IVD goods, an increase in research efforts, the availability of new technologies, and the higher incidence of chronic diseases.


Segmentation of Flow Cytometry in Oncology and Immunology Market-

By Offering


  • Products
  • Instruments
  • Reagents and Consumables
  • Software
  • Services

By Technology-

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

By Type-

  • Immunology
  • Oncology
    • Hematological Malignancies
      • Hematological Malignancies (by Type)
        • Lymphoma
        • Leukemia
        • Myeloma
        • Other Hematological Malignancies
        • Hematological Malignancies (by Technology)
        • Solid Tumor
          • Solid Tumor (by Type)
            • Breast Cancer
            • Prostate Cancer
            • Colorectal Cancer
            • Lung Cancer
            • Liver Cancer
            • Ovarian Cancer
            • Other Solid Tumors
          • Solid Tumor (by Technology)

By Application-

  • Translational Research
  • Clinical Research
    • Screening and Diagnostics
    • Monitoring and Treatment

By End User-

  • Hospitals, Diagnostic Laboratories, and Reference Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


For More Customization @ https://www.insightaceanalytic.com/customisation/1491

Media Contact
Company Name: InsightAce Analytic Pvt. Ltd
Contact Person: Diana D’Souza
Email: Send Email
Country: United States
Website: https://www.insightaceanalytic.com/